Blog

Tech Nation Visa: the gateway to world-leading UK tech jobs

At BenevolentAI we are always on the lookout for exceptional people to join us on our mission to re-engineer drug discovery and deliver life changing medicines to patients.


Our teams are curious, open to new ideas and passionate about making a positive impact on the world. At BenevolentAI we value different experiences, skills, and backgrounds and believe a diverse and inclusive environment is necessary to push technological and scientific boundaries. 

A globally diverse perspective is important, which is why we encourage the best tech talent from around the world to join us. As such, we want to draw attention to the Tech Nation Visa, also known as the Global Talent Visa in digital technology, which is a great initiative that enables the brightest international talent to live and work in the UK. 

Tech Nation, a close partner of BenevolentAI, has been designated by the Home Office to endorse applications for this Visa.  The application process is based on your unique background, skills, and achievements and there are two pathways to apply, depending on your experience:  Exceptional Talent and Exceptional Promise. The Tech Nation visa is highly flexible, not tied to a specific job, company or location. Applicants can have experience in any tech subsector and either business or technical backgrounds. It is granted for up to 5 years, with the ability to extend as many times as required. The Tech Nation Visa can also lead to permanent residency here in the UK.

Whether you have an established career in tech, or are finding your feet, the UK’s flourishing tech scene provides rich opportunities for entrepreneurs to set up or scale a business, or find employment at an existing firm. 52% of those endorsed last year by Tech Nation are now employed at leading UK tech firms, helping to fill existing talent gaps, while 28% have launched their own businesses. 

At BenevolentAI you have the chance to work alongside our world-leading experts, building tech which has real impact and contributes directly to our mission to improve patients’ lives. If you are a talented and creative individual interested in joining us on this mission, this could be your answer. 

Start building your career today, and find out more on the Tech Nation Visa guide here. 

Best of luck in your application.

The BenevolentAI Team


More Posts

You Might Also Like

Blog
Transforming drug discovery with AI: how we’re building and nurturing the best talent for the job
At BenevolentAI, we are on a mission to bring life-changing medicines to patients, and we are looking for collaborative, mission-driven people to join our tech, drug discovery and business operations teams in London, Cambridge and New York.
Oct 17, 2021
News
BenevolentAI identifies novel target for ulcerative colitis and advances candidate to IND/CTA-enabling studies
BenevolentAI’s AI-Drug Discovery platform uncovered a novel target not previously linked to ulcerative colitis and advanced candidate to preclinical studies.
Oct 14, 2021
Blog
Measuring bias: moving towards more inclusive health research outcomes #stateofai
Having shared our open-source Diversity Analysis Tool last year, we were tasked to investigate and demonstrate the lack of diversity in biomedical data as part of the State of AI Report 2021.
Oct 12, 2021
Blog
Expert-augmented computational drug discovery for rare diseases
Combining scientific expertise, computational tools and our AI-enhanced biomedical knowledge graph to successfully uncover a new drug combination for treating a rare brain cancer in children.
Sep 28, 2021
News
BenevolentAI appoints Dr John Orloff to its Board of Directors
Biopharmaceutical veteran Dr John Orloff joins the BenevolentAI Board as a Non-Executive Director as it scales the development of its leading AI-derived drug pipeline.
Sep 9, 2021
Blog
AI in Drug Discovery
This blog seeks to demystify the application of artificial intelligence (AI) and machine learning (ML) in drug discovery by exploring some of the challenges, opportunities and progress that has been achieved in the field so far.
Jul 13, 2021